1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 5:Summary of findings for an intervention involving reassurance that MR imaging findings are normal versus a factual explanation of MR imaging reporta
Follow-Up Period/Outcome Outcome Measure (Scale) Effect Size, Mean Difference (95% CI) Short Pain VAS (0–10) 3.76 (−4.55 to −2.97) Pain self-efficacy PSEQ–2 (0–12) 4.68 (−5.62 to −3.74) Quality of life SF-12 (physical) (0–100) 8.46 (−13.12 to −3.80) SF-12 (mental) (0–100) 10.48 (−14.76 to −6.20)
Note:—VAS indicates visual analog scale; PSEQ –2, Pain Self-Efficacy Questionnaire–2; SF-12, 12-item Short Form Health survey (physical and mental dimensions).
↵a Rajasekaran et al, 2021,27 n = 44. GRADE = low. Negative values of the mean difference estimate represent an effect in favor of the intervention group.